How accurate are ABEONA THERAPEUTICS INC. stock predictions?

Our AI model shows a 25% Spearman correlation coefficient for ABEO predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence ABEONA THERAPEUTICS INC. stock price forecasts?

Our analysis considers financial metrics, sector trends, market sentiment, technical indicators, and macroeconomic factors.

ABEONA THERAPEUTICS INC. (ABEO) Prévisions boursières 2025 - Prédiction des prix et analyse par IA

ABEONA THERAPEUTICS INC. (ABEO) Prévision du cours de l'action par IA et analyse d'investissement

Date de la dernière analyse: décembre 05, 2025

Chargement du graphique interactif des prix et de l'analyse technique de ABEONA THERAPEUTICS INC....

ABEONA THERAPEUTICS INC. (ABEO) - Analyse complète des actions et recherche en matière d'investissement

Plongez au cœur du profil commercial, de la performance financière, des prévisions de l'IA et du positionnement concurrentiel de ABEONA THERAPEUTICS INC. pour prendre des décisions d'investissement éclairées.

Comprendre l'aperçu de l'entreprise

Ce que couvre cette section: Informations commerciales essentielles sur ABEONA THERAPEUTICS INC., y compris la classification sectorielle, le positionnement dans l'industrie et la structure organisationnelle.

Comment interpréter: La taille de l'entreprise, le secteur et le nombre d'employés fournissent le contexte pour la position sur le marché et le potentiel de croissance. La direction et la date de fondation indiquent la stabilité et l'expérience.

Pour ABEONA THERAPEUTICS INC.: ABEONA THERAPEUTICS INC. opère dans le secteur Life Sciences, en faisant un investissement émergent à petite capitalisation.

ABEONA THERAPEUTICS INC. (Symbole boursier: ABEO) est une entreprise leader dans le secteur Life Sciences. , opérant spécifiquement dans le secteur Pharmaceutical Preparations..

L'organisation emploie environ 99 professionnels dans le monde entier. .

L'entreprise s'est imposée comme une opportunité d'investissement émergente avec un potentiel de croissance substantiel.

Comprendre la performance financière

Ce que signifient ces indicateurs: Indicateurs financiers clés montrant l'échelle des revenus, la rentabilité, la valeur de marché et les rendements pour les actionnaires de ABEONA THERAPEUTICS INC..

Comment les lire: Des ROE/ROA plus élevés indiquent une meilleure efficacité de gestion. Les pourcentages de marge montrent le profit à différents niveaux opérationnels.

Pour ABEONA THERAPEUTICS INC.: Avec 12 M$ de revenus annuels et -419,7% de marge nette, l'entreprise démontre rentabilité en développement.

Revenus annuels: $12 millions générant une marge bénéficiaire nette de -419,7% .

Capitalisation boursière: $255 millions - Classé comme investissement en petites capitalisations offrant un fort potentiel de croissance.

Rendement des fonds propres (ROE): -142,6% - Inférieur à la moyenne l'efficacité du rendement de l'actionnaire, indiquant domaines d'amélioration opérationnelle.

Comprendre les prévisions boursières de l'IA

Ce que signifient ces prévisions: Prévisions alimentées par IA pour l'action ABEONA THERAPEUTICS INC. utilisant des algorithmes d'apprentissage automatique entraînés sur des données de marché historiques et des indicateurs techniques.

Comment interpréter: Les pourcentages positifs indiquent des hausses de prix attendues, les valeurs négatives suggèrent des baisses potentielles. Les scores de précision montrent la fiabilité historique des prédictions.

Pour ABEONA THERAPEUTICS INC.: Débloquez l'accès premium pour voir les prévisions détaillées de l'IA et les objectifs de prix.

🚀 Débloquer les prédictions Premium de l'IA pour accéder à nos prévisions avancées d'apprentissage automatique pour l'action ABEONA THERAPEUTICS INC., y compris des objectifs de prix à 7, 30 et 90 jours avec des intervalles de confiance et des évaluations de risque.

Comprendre la position sur le marché

Ce que couvre cette analyse: Le positionnement concurrentiel, la dynamique de marché, l'efficacité opérationnelle et les avantages stratégiques de ABEONA THERAPEUTICS INC. dans son industrie.

Comment évaluer: Une génération de flux de trésorerie forte, des marges saines et un leadership sur le marché indiquent des avantages concurrentiels. Les taux de croissance montrent un potentiel d'expansion.

Pour ABEONA THERAPEUTICS INC.: Analyse du positionnement sur le marché basée sur les indicateurs financiers et opérationnels disponibles.

ABEONA THERAPEUTICS INC. est en concurrence stratégique dans le secteur très dynamique de le marché Pharmaceutical Preparations, représentant un investissement émergent en petite capitalisation avec un potentiel de croissance substantiel et des capacités de disruption du marché .

L'entreprise maintient une marge brute saine de 27,9%, ce qui témoigne d'un fort pouvoir de fixation des prix et d'une solide efficacité opérationnelle.

ABEONA THERAPEUTICS INC. (ABEO) Analyse fondamentale et données de transactions d'initiés (Rapports financiers trimestriels)

Données financières trimestrielles complètes, tendances des bénéfices, transactions d'initiés et participations institutionnelles pour ABEONA THERAPEUTICS INC. analyse des actions.

Chargement de l'analyse fondamentale complète de ABEONA THERAPEUTICS INC. et des données de transactions d'initiés...

Plongez dans l'analyse de la santé financière de ABEONA THERAPEUTICS INC., de ses indicateurs de valorisation et de son efficacité opérationnelle pour prendre des décisions d'investissement éclairées.

Comprendre les indicateurs de valorisation

Ce que signifient ces indicateurs: Les indicateurs de valorisation permettent de déterminer si le prix de l'action ABEONA THERAPEUTICS INC. est juste par rapport à ses bénéfices, ses actifs et sa position sur le marché.

Comment les lire: Des ratios P/E plus faibles peuvent indiquer des actions sous-évaluées, tandis que des ratios plus élevés suggèrent des attentes de croissance. Le ratio P/B compare la valeur de marché à la valeur comptable.

Pour ABEONA THERAPEUTICS INC.: Avec un ratio P/E de 3,09, le marché considère l'action comme potentiellement sous-évaluée.

P/E Ratio 3,09x

P/B Ratio 1,49x

Market Cap $255M

EPS $-2,53

Valeur comptable/action $3,27

FCF/action $-0,58

Comprendre les indicateurs de rentabilité

Ce que signifient ces indicateurs: Ces ratios mesurent l'efficacité avec laquelle ABEONA THERAPEUTICS INC. convertit le chiffre d'affaires en profit et génère des rendements pour les actionnaires.

Comment les lire: Des ROE/ROA plus élevés indiquent une meilleure efficacité de gestion. Les pourcentages de marge montrent le profit à différents niveaux opérationnels.

Pour ABEONA THERAPEUTICS INC.: Un ROE de -142,6% indique une marge d'amélioration en matière de création de valeur pour l'actionnaire.

ROE -142,6%

ROA -91,3%

ROIC -121,8%

Gross Margin 27,9%

Operating Margin -452,7%

Net Margin -419,7%

EBT Margin -542,7%

Comprendre les indicateurs de santé financière

Ce que signifient ces indicateurs: Ces ratios évaluent la capacité de ABEONA THERAPEUTICS INC. à faire face à ses obligations à court terme et à gérer efficacement ses niveaux d'endettement.

Comment les lire: Un ratio de liquidité générale >2 est généralement bon, un ratio de liquidité immédiate >1 indique une forte liquidité. Des ratios D/E plus faibles indiquent une gestion conservatrice de la dette.

Pour ABEONA THERAPEUTICS INC.: Un ratio de liquidité générale de 3,18 indique une forte liquidité.

Current Ratio 3,18x

Quick Ratio 2,54x

D/E Ratio 0,23x

Financial Leverage 1,75x

Interest Coverage -35,6x

Working Capital $56M

Comprendre les indicateurs de flux de trésorerie

Ce que signifient ces indicateurs: Les indicateurs de flux de trésorerie révèlent la capacité de ABEONA THERAPEUTICS INC. à générer des liquidités à partir de ses activités et à financer ses initiatives de croissance.

Comment les lire: Un flux de trésorerie d'exploitation positif est essentiel. Le flux de trésorerie disponible indique les fonds disponibles pour les dividendes, les rachats d'actions ou les investissements.

Pour ABEONA THERAPEUTICS INC.: Flux de trésorerie disponible de -70 M$ indique des défis de trésorerie nécessitant une attention particulière.

Operating Cash Flow $-66M

Free Cash Flow $-70M

Capital Spending $-4M

FCF/Sales -381,9%

CapEx/Sales 113,9%

Comprendre les indicateurs d'efficacité opérationnelle

Ce que signifient ces indicateurs: Ces ratios mesurent l'efficacité avec laquelle ABEONA THERAPEUTICS INC. utilise ses actifs et gère son fonds de roulement.

Comment les lire: Des taux de rotation plus élevés indiquent une utilisation efficace des actifs. Des délais de recouvrement plus courts témoignent d'une gestion efficace du crédit.

Pour ABEONA THERAPEUTICS INC.: Une rotation des actifs de 0,03x suggère une marge d'amélioration en matière d' utilisation des actifs.

Asset Turnover 0,03x

Receivables Turnover 1,0x

Inventory Turnover 1,6x

Fixed Assets Turnover 0,2x

Délai moyen de recouvrement 365 jours

Jours de stock 236 jours

Délai de paiement fournisseurs 4237 jours

Cycle de conversion de trésorerie -2280 jours

Comprendre les données des états financiers

Ce que signifient ces indicateurs: Chiffres clés du compte de résultat et du bilan de ABEONA THERAPEUTICS INC. montrant la performance financière absolue.

Comment les lire: Le chiffre d'affaires montre l'échelle de l'entreprise, tandis que les marges indiquent la rentabilité. Les éléments du bilan révèlent la structure financière.

Pour ABEONA THERAPEUTICS INC.: Avec un chiffre d'affaires annuel de 12M$, ABEONA THERAPEUTICS INC. représente une opération plus petite mais avec un potentiel de forte croissance.

Compte de résultat ($ Millions)

Chiffre d'affaires total $12M

Dépenses de R&D $33M

Frais de vente et d'administration $620M

Points clés du bilan (% Des actifs)

Total Current Assets 71%

Cash & Short-term Investments 57%

Total Liabilities 43%

Short-term Debt 1%

Accounts Receivable 4%

Inventory 11%

Informations sur les dividendes et les actionnaires

Shares Outstanding 52M

Indicateurs de croissance (annuel)

EPS Growth -42,1%

Dernières ABEONA THERAPEUTICS INC. Actualités boursières et analyses de marché

Dernières nouvelles, rapports d'analystes et mises à jour du marché concernant le cours de l'action ABEONA THERAPEUTICS INC. (ABEO) et les perspectives d'investissement.

📰 Nous sommes en train de mettre à jour notre flux de nouvelles pour ABEONA THERAPEUTICS INC.. Revenez bientôt pour obtenir les dernières analyses de marché et les mises à jour de l'entreprise.

ABEONA THERAPEUTICS INC. Concurrents et analyse des pairs - Life Sciences Secteur

Analyse comparative de ABEONA THERAPEUTICS INC. par rapport à ses pairs et à ses concurrents dans le secteur Life Sciences, avec des prévisions alimentées par l'IA et des indicateurs financiers clés.

Entreprise	Symbole du téléscripteur	Prévisions AI à 90 jours	Capitalisation boursière (en millions d'USD)	Ratio P/E	Rapport P/B
Aardvark Therapeutics, Inc.	AARD	Unlock Forecast - 30 Days FREE Trial	$295M	x	2,4x
AbbVie Inc.	ABBV	Unlock Forecast - 30 Days FREE Trial	$400614M	167,8x	0,0x
AbCellera Biologics Inc.	ABCL	Unlock Forecast - 30 Days FREE Trial	$1088M	-5,3x	1,1x
ABEONA THERAPEUTICS INC.	ABEO	Unlock Forecast - 30 Days FREE Trial	$255M	3,1x	1,5x
ABBOTT LABORATORIES	ABT	Unlock Forecast - 30 Days FREE Trial	$218785M	15,7x	4,3x
Arbutus Biopharma Corp	ABUS	Unlock Forecast - 30 Days FREE Trial	$831M	-8,3x	10,7x
ABVC BIOPHARMA, INC.	ABVC	Unlock Forecast - 30 Days FREE Trial	$66M	-0,3x	5,4x
ACADIA PHARMACEUTICALS INC	ACAD	Unlock Forecast - 30 Days FREE Trial	$4491M	17,2x	4,9x
Adicet Bio, Inc.	ACET	Unlock Forecast - 30 Days FREE Trial	$51M	-0,4x	0,5x
Aclaris Therapeutics, Inc.	ACRS	Unlock Forecast - 30 Days FREE Trial	$319M	-4,5x	2,7x
Acrivon Therapeutics, Inc.	ACRV	Unlock Forecast - 30 Days FREE Trial	$74M	-2,8x	0,6x
ACTUATE THERAPEUTICS, INC.	ACTU	Unlock Forecast - 30 Days FREE Trial	$171M	x	15,6x
Accustem Sciences Inc.	ACUT	Unlock Forecast - 30 Days FREE Trial	$13M	x	x
Acurx Pharmaceuticals, Inc.	ACXP	Unlock Forecast - 30 Days FREE Trial	$7M	-0,8x	1,9x
Adagene Inc.	ADAG	Unlock Forecast - 30 Days FREE Trial	$118M	x	3,1x
ADC Therapeutics SA	ADCT	Unlock Forecast - 30 Days FREE Trial	$378M	-9,2x	-1,3x
ADIAL PHARMACEUTICALS, INC.	ADIL	Unlock Forecast - 30 Days FREE Trial	$7M	-0,1x	1,7x
Aditxt, Inc.	ADTX	Unlock Forecast - 30 Days FREE Trial	$0M	0,0x	1,0x
AGIOS PHARMACEUTICALS, INC.	AGIO	Unlock Forecast - 30 Days FREE Trial	$1598M	3,7x	1,2x
Ainos, Inc.	AIMD	Unlock Forecast - 30 Days FREE Trial	$10M	-0,4x	1,0x
Akebia Therapeutics, Inc.	AKBA	Unlock Forecast - 30 Days FREE Trial	$421M	-5,4x	10,1x
Akero Therapeutics, Inc.	AKRO	Unlock Forecast - 30 Days FREE Trial	$4379M	-8,7x	4,6x
Akari Therapeutics Plc	AKTX	Unlock Forecast - 30 Days FREE Trial	$31702M	-2,0x	1397,3x
Aldeyra Therapeutics, Inc.	ALDX	Unlock Forecast - 30 Days FREE Trial	$285M	-5,1x	5,8x
Allarity Therapeutics, Inc.	ALLR	Unlock Forecast - 30 Days FREE Trial	$21M	-0,2x	1,8x
ALUMIS INC.	ALMS	Unlock Forecast - 30 Days FREE Trial	$651M	x	1,7x
ALNYLAM PHARMACEUTICALS, INC.	ALNY	Unlock Forecast - 30 Days FREE Trial	$60376M	1385,9x	258,1x
Altimmune, Inc.	ALT	Unlock Forecast - 30 Days FREE Trial	$512M	-5,7x	2,8x
ALX ONCOLOGY HOLDINGS INC	ALXO	Unlock Forecast - 30 Days FREE Trial	$73M	-0,4x	1,6x
Alzamend Neuro, Inc.	ALZN	Unlock Forecast - 30 Days FREE Trial	$7M	-0,1x	1,3x
Amylyx Pharmaceuticals, Inc.	AMLX	Unlock Forecast - 30 Days FREE Trial	$1591M	-1,5x	4,8x
Amphastar Pharmaceuticals, Inc.	AMPH	Unlock Forecast - 30 Days FREE Trial	$1258M	11,3x	2,8x
AMARIN CORP PLC\UK	AMRN	Unlock Forecast - 30 Days FREE Trial	$6870M	-4,5x	15,0x
Amneal Pharmaceuticals, Inc.	AMRX	Unlock Forecast - 30 Days FREE Trial	$3865M	655,1x	0,0x
ANAPTYSBIO, INC	ANAB	Unlock Forecast - 30 Days FREE Trial	$1194M	-2,5x	23,8x
Anebulo Pharmaceuticals, Inc.	ANEB	Unlock Forecast - 30 Days FREE Trial	$97M	-4,3x	9,9x
ANI PHARMACEUTICALS INC	ANIP	Unlock Forecast - 30 Days FREE Trial	$1730M	42,7x	3,4x
Anixa Biosciences Inc	ANIX	Unlock Forecast - 30 Days FREE Trial	$151M	-15,0x	9,1x
Annexon, Inc.	ANNX	Unlock Forecast - 30 Days FREE Trial	$700M	-4,1x	4,3x
Alto Neuroscience, Inc.	ANRO	Unlock Forecast - 30 Days FREE Trial	$364M	x	3,3x
Annovis Bio, Inc.	ANVS	Unlock Forecast - 30 Days FREE Trial	$94M	-1,0x	7,2x
Apellis Pharmaceuticals, Inc.	APLS	Unlock Forecast - 30 Days FREE Trial	$2807M	62,4x	7,0x
Applied Therapeutics, Inc.	APLT	Unlock Forecast - 30 Days FREE Trial	$38M	-0,7x	6,9x
Aprea Therapeutics, Inc.	APRE	Unlock Forecast - 30 Days FREE Trial	$8M	-1,2x	0,7x
Apimeds Pharmaceuticals US, Inc.	APUS	Unlock Forecast - 30 Days FREE Trial	$36M	x	4,5x
Aptevo Therapeutics Inc.	APVO	Unlock Forecast - 30 Days FREE Trial	$19M	-0,1x	1,1x
Aquestive Therapeutics, Inc.	AQST	Unlock Forecast - 30 Days FREE Trial	$778M	-10,7x	-6,9x
Arcturus Therapeutics Holdings Inc.	ARCT	Unlock Forecast - 30 Days FREE Trial	$194M	-7,0x	0,9x
ARDELYX, INC.	ARDX	Unlock Forecast - 30 Days FREE Trial	$1438M	-21,3x	9,3x
Arcutis Biotherapeutics, Inc.	ARQT	Unlock Forecast - 30 Days FREE Trial	$3748M	-6,6x	23,7x
ARTELO BIOSCIENCES, INC.	ARTL	Unlock Forecast - 30 Days FREE Trial	$3M	-0,7x	42,0x
ARVINAS, INC.	ARVN	Unlock Forecast - 30 Days FREE Trial	$901M	-4,8x	1,6x
ARROWHEAD PHARMACEUTICALS, INC.	ARWR	Unlock Forecast - 30 Days FREE Trial	$8338M	-4,7x	17,9x
Aspire Biopharma Holdings, Inc.	ASBP	Unlock Forecast - 30 Days FREE Trial	$5M	x	x
ASSEMBLY BIOSCIENCES, INC.	ASMB	Unlock Forecast - 30 Days FREE Trial	$562M	-1,5x	3,1x
Assertio Holdings, Inc.	ASRT	Unlock Forecast - 30 Days FREE Trial	$71M	-0,2x	0,7x
Atai Beckley N.V.	ATAI	Unlock Forecast - 30 Days FREE Trial	$1058M	-4,4x	6,6x
Actinium Pharmaceuticals, Inc.	ATNM	Unlock Forecast - 30 Days FREE Trial	$43M	-4,1x	3,1x
ATOSSA THERAPEUTICS, INC.	ATOS	Unlock Forecast - 30 Days FREE Trial	$101M	-6,2x	2,0x
AVENUE THERAPEUTICS, INC.	ATXI	Unlock Forecast - 30 Days FREE Trial	$2M	-9,5x	0,7x
Astria Therapeutics, Inc.	ATXS	Unlock Forecast - 30 Days FREE Trial	$730M	-4,7x	3,1x
Aurinia Pharmaceuticals Inc.	AUPH	Unlock Forecast - 30 Days FREE Trial	$2018M	25,9x	5,5x
ArriVent BioPharma, Inc.	AVBP	Unlock Forecast - 30 Days FREE Trial	$1023M	x	3,4x
AVADEL PHARMACEUTICALS PLC	AVDL	Unlock Forecast - 30 Days FREE Trial	$2077M	-10,2x	21,1x
Atea Pharmaceuticals, Inc.	AVIR	Unlock Forecast - 30 Days FREE Trial	$247M	-1,5x	0,8x
Avalo Therapeutics, Inc.	AVTX	Unlock Forecast - 30 Days FREE Trial	$204M	-0,1x	2,2x
AXIM BIOTECHNOLOGIES, INC.	AXIM	Unlock Forecast - 30 Days FREE Trial	$6M	x	x
Axsome Therapeutics, Inc.	AXSM	Unlock Forecast - 30 Days FREE Trial	$7507M	-19,9x	101,8x
AYTU BIOPHARMA, INC	AYTU	Unlock Forecast - 30 Days FREE Trial	$22M	-0,3x	0,9x
Azitra, Inc.	AZTR	Unlock Forecast - 30 Days FREE Trial	$2M	-0,2x	0,9x
BridgeBio Pharma, Inc.	BBIO	Unlock Forecast - 30 Days FREE Trial	$14186M	-11,6x	-5,4x
Bicara Therapeutics Inc.	BCAX	Unlock Forecast - 30 Days FREE Trial	$1028M	x	2,6x
BriaCell Therapeutics Corp.	BCTX	Unlock Forecast - 30 Days FREE Trial	$18M	-1,7x	1,0x
BICYCLE THERAPEUTICS PLC	BCYC	Unlock Forecast - 30 Days FREE Trial	$496M	-6,0x	0,8x
BIOADAPTIVES, INC.	BDPT	Unlock Forecast - 30 Days FREE Trial	$0M	x	x
BeOne Medicines Ltd.	BEIGF	Unlock Forecast - 30 Days FREE Trial	$40913M	x	9,9x
BullFrog AI Holdings, Inc.	BFRG	Unlock Forecast - 30 Days FREE Trial	$10M	-2,9x	5,4x
Biofrontera Inc.	BFRI	Unlock Forecast - 30 Days FREE Trial	$10M	-0,1x	17,9x
Bausch Health Companies Inc.	BHC	Unlock Forecast - 30 Days FREE Trial	$2734M	7,6x	-2,0x
Biohaven Ltd.	BHVN	Unlock Forecast - 30 Days FREE Trial	$1017M	-4,6x	6,5x
BioAge Labs, Inc.	BIOA	Unlock Forecast - 30 Days FREE Trial	$405M	x	1,5x
BIOVIE INC.	BIVI	Unlock Forecast - 30 Days FREE Trial	$11M	-0,6x	0,5x
BELITE BIO, INC	BLTE	Unlock Forecast - 30 Days FREE Trial	$4372M	x	48,4x
Biomea Fusion, Inc.	BMEA	Unlock Forecast - 30 Days FREE Trial	$65M	-1,6x	4,2x
BIOMARIN PHARMACEUTICAL INC	BMRN	Unlock Forecast - 30 Days FREE Trial	$10258M	19,7x	1,7x
BRISTOL MYERS SQUIBB CO	BMY	Unlock Forecast - 30 Days FREE Trial	$106334M	17,6x	5,7x
BRISTOL MYERS SQUIBB CO	BMYMP	Unlock Forecast - 30 Days FREE Trial	$1752215M	296,8x	94,5x
Benitec Biopharma Inc.	BNTC	Unlock Forecast - 30 Days FREE Trial	$342M	-0,6x	3,7x
Boundless Bio, Inc.	BOLD	Unlock Forecast - 30 Days FREE Trial	$25M	-15,1x	0,2x
Bolt Biotherapeutics, Inc.	BOLT	Unlock Forecast - 30 Days FREE Trial	$10M	-0,3x	0,3x
BIO-PATH HOLDINGS, INC.	BPTH	Unlock Forecast - 30 Days FREE Trial	$1M	0,0x	-1,2x
Bioquest Corp	BQST	Unlock Forecast - 30 Days FREE Trial	$6M	x	x
Barinthus Biotherapeutics plc.	BRNS	Unlock Forecast - 30 Days FREE Trial	$32M	-0,6x	0,4x
BioXcel Therapeutics, Inc.	BTAI	Unlock Forecast - 30 Days FREE Trial	$41M	-0,1x	-0,1x
BeyondSpring Inc.	BYSI	Unlock Forecast - 30 Days FREE Trial	$85M	x	-3,1x
CalciMedica, Inc.	CALC	Unlock Forecast - 30 Days FREE Trial	$61M	0,4x	7,0x
Camp4 Therapeutics Corp	CAMP	Unlock Forecast - 30 Days FREE Trial	$73M	-0,1x	1,3x
Can-Fite BioPharma Ltd.	CANF	Unlock Forecast - 30 Days FREE Trial	$1389M	x	331,9x
Carisma Therapeutics Inc.	CARM	Unlock Forecast - 30 Days FREE Trial	$3M	-0,7x	0,1x
CASI Pharmaceuticals, Inc.	CASI	Unlock Forecast - 30 Days FREE Trial	$16M	-1,4x	8,5x
Perspective Therapeutics, Inc.	CATX	Unlock Forecast - 30 Days FREE Trial	$168M	-2,8x	0,7x
CRESCENT BIOPHARMA, INC.	CBIO	Unlock Forecast - 30 Days FREE Trial	$182M	-6,5x	1,6x
CDT Equity Inc.	CDT	Unlock Forecast - 30 Days FREE Trial	$3M	-0,7x	0,6x
Cingulate Inc.	CING	Unlock Forecast - 30 Days FREE Trial	$22M	-0,6x	6,4x
Cell Source, Inc.	CLCS	Unlock Forecast - 30 Days FREE Trial	$16M	x	x
Clene Inc.	CLNN	Unlock Forecast - 30 Days FREE Trial	$108M	-7,3x	-6,9x
Clearside Biomedical, Inc.	CLSD	Unlock Forecast - 30 Days FREE Trial	$2M	-2,0x	-0,7x
Climb Bio, Inc.	CLYM	Unlock Forecast - 30 Days FREE Trial	$129M	-1,4x	0,7x
Chemomab Therapeutics Ltd.	CMMB	Unlock Forecast - 30 Days FREE Trial	$1084M	10,9x	111,8x
COMPASS Pathways plc	CMPS	Unlock Forecast - 30 Days FREE Trial	$561M	0,0x	14,9x
CNS Pharmaceuticals, Inc.	CNSP	Unlock Forecast - 30 Days FREE Trial	$4M	0,0x	0,4x
Centessa Pharmaceuticals plc	CNTA	Unlock Forecast - 30 Days FREE Trial	$3973M	-11,0x	13,2x
Connect Biopharma Holdings Ltd	CNTB	Unlock Forecast - 30 Days FREE Trial	$157M	x	2,8x
Context Therapeutics Inc.	CNTX	Unlock Forecast - 30 Days FREE Trial	$103M	-1,5x	1,4x
Cocrystal Pharma, Inc.	COCP	Unlock Forecast - 30 Days FREE Trial	$14M	-1,0x	1,8x
Cogent Biosciences, Inc.	COGT	Unlock Forecast - 30 Days FREE Trial	$5421M	-3,7x	17,9x
CORCEPT THERAPEUTICS INC	CORT	Unlock Forecast - 30 Days FREE Trial	$10332M	97,4x	16,4x
Coya Therapeutics, Inc.	COYA	Unlock Forecast - 30 Days FREE Trial	$107M	-6,8x	3,9x
CHINA PHARMA HOLDINGS, INC.	CPHI	Unlock Forecast - 30 Days FREE Trial	$5M	-0,2x	0,6x
CUMBERLAND PHARMACEUTICALS INC	CPIX	Unlock Forecast - 30 Days FREE Trial	$34M	-4,5x	1,3x
CATALYST PHARMACEUTICALS, INC.	CPRX	Unlock Forecast - 30 Days FREE Trial	$2845M	13,1x	3,1x
Corbus Pharmaceuticals Holdings, Inc.	CRBP	Unlock Forecast - 30 Days FREE Trial	$128M	-2,0x	1,4x
CorMedix Inc.	CRMD	Unlock Forecast - 30 Days FREE Trial	$837M	5,2x	2,2x
Crinetics Pharmaceuticals, Inc.	CRNX	Unlock Forecast - 30 Days FREE Trial	$4483M	-15,9x	4,2x
CervoMed Inc.	CRVO	Unlock Forecast - 30 Days FREE Trial	$92M	-0,7x	3,5x
Corvus Pharmaceuticals, Inc.	CRVS	Unlock Forecast - 30 Days FREE Trial	$689M	-13,7x	9,6x
CytomX Therapeutics, Inc.	CTMX	Unlock Forecast - 30 Days FREE Trial	$512M	18,3x	4,8x
Contineum Therapeutics, Inc.	CTNM	Unlock Forecast - 30 Days FREE Trial	$214M	x	1,1x
CITIUS ONCOLOGY, INC.	CTOR	Unlock Forecast - 30 Days FREE Trial	$98M	3,9x	3,0x
Hepion Pharmaceuticals, Inc.	CTRVP	Unlock Forecast - 30 Days FREE Trial	$0M	x	0,0x
Citius Pharmaceuticals, Inc.	CTXR	Unlock Forecast - 30 Days FREE Trial	$19M	-5,3x	0,3x
Cue Biopharma, Inc.	CUE	Unlock Forecast - 30 Days FREE Trial	$49M	-1,2x	3,7x
Cadrenal Therapeutics, Inc.	CVKD	Unlock Forecast - 30 Days FREE Trial	$19M	-11,1x	7,1x
CV Sciences, Inc.	CVSI	Unlock Forecast - 30 Days FREE Trial	$6M	x	3,6x
Cyclerion Therapeutics, Inc.	CYCN	Unlock Forecast - 30 Days FREE Trial	$6M	-5,2x	0,6x
CytoDyn Inc.	CYDY	Unlock Forecast - 30 Days FREE Trial	$401M	86,7x	x
Cryoport, Inc.	CYRX	Unlock Forecast - 30 Days FREE Trial	$480M	6,7x	0,9x
CYTOKINETICS INC	CYTK	Unlock Forecast - 30 Days FREE Trial	$8M	-9,4x	-13,9x
Dare Bioscience, Inc.	DARE	Unlock Forecast - 30 Days FREE Trial	$26M	2,9x	9,0x
Day One Biopharmaceuticals, Inc.	DAWN	Unlock Forecast - 30 Days FREE Trial	$853M	-8,9x	1,9x
Journey Medical Corp	DERM	Unlock Forecast - 30 Days FREE Trial	$191M	24,1x	7,4x
DiaMedica Therapeutics Inc.	DMAC	Unlock Forecast - 30 Days FREE Trial	$441M	-4,2x	8,5x
Dianthus Therapeutics, Inc. /DE/	DNTH	Unlock Forecast - 30 Days FREE Trial	$1916M	-3,2x	3,5x
Dermata Therapeutics, Inc.	DRMA	Unlock Forecast - 30 Days FREE Trial	$3M	-0,2x	0,7x
DURECT CORP	DRRX	Unlock Forecast - 30 Days FREE Trial	$59M	-1,2x	17,0x
Design Therapeutics, Inc.	DSGN	Unlock Forecast - 30 Days FREE Trial	$558M	-7,6x	2,8x
DYNAVAX TECHNOLOGIES CORP	DVAX	Unlock Forecast - 30 Days FREE Trial	$1286M	88,2x	2,4x
Dogwood Therapeutics, Inc.	DWTX	Unlock Forecast - 30 Days FREE Trial	$14M	-2,9x	1,9x
Dyne Therapeutics, Inc.	DYN	Unlock Forecast - 30 Days FREE Trial	$2945M	-7,8x	4,3x
Emergent BioSolutions Inc.	EBS	Unlock Forecast - 30 Days FREE Trial	$630M	8,3x	1,1x
Edesa Biotech, Inc.	EDSA	Unlock Forecast - 30 Days FREE Trial	$12M	-1,3x	0,9x
PMGC Holdings Inc.	ELAB	Unlock Forecast - 30 Days FREE Trial	$4M	-8,2x	0,5x
Elanco Animal Health Inc	ELAN	Unlock Forecast - 30 Days FREE Trial	$10881M	302,2x	1,6x
ELITE PHARMACEUTICALS INC /NV/	ELTP	Unlock Forecast - 30 Days FREE Trial	$553M	x	9,0x
Elicio Therapeutics, Inc.	ELTX	Unlock Forecast - 30 Days FREE Trial	$162M	-1,9x	42,3x
Enliven Therapeutics, Inc.	ELVN	Unlock Forecast - 30 Days FREE Trial	$1268M	-13,3x	2,7x
Enlivex Therapeutics Ltd.	ENLV	Unlock Forecast - 30 Days FREE Trial	$29M	x	1,5x
ENANTA PHARMACEUTICALS INC	ENTA	Unlock Forecast - 30 Days FREE Trial	$313M	-1,3x	4,8x
Entero Therapeutics, Inc.	ENTO	Unlock Forecast - 30 Days FREE Trial	$8M	0,0x	0,3x
Enveric Biosciences, Inc.	ENVB	Unlock Forecast - 30 Days FREE Trial	$3M	-0,1x	0,9x
Evolus, Inc.	EOLS	Unlock Forecast - 30 Days FREE Trial	$440M	-13,1x	-89,8x
ESSA Pharma Inc.	EPIX	Unlock Forecast - 30 Days FREE Trial	$9M	-2,7x	0,1x
Equillium, Inc.	EQ	Unlock Forecast - 30 Days FREE Trial	$55M	-3,2x	1,8x
Erasca, Inc.	ERAS	Unlock Forecast - 30 Days FREE Trial	$899M	-3,1x	2,6x
Esperion Therapeutics, Inc.	ESPR	Unlock Forecast - 30 Days FREE Trial	$742M	-4,2x	-0,2x
89bio, Inc.	ETNB	Unlock Forecast - 30 Days FREE Trial	$2201M	-3,5x	4,2x
Eton Pharmaceuticals, Inc.	ETON	Unlock Forecast - 30 Days FREE Trial	$452M	-66,2x	19,5x
Evofem Biosciences, Inc.	EVFM	Unlock Forecast - 30 Days FREE Trial	$1M	-0,1x	-0,1x
Edgewise Therapeutics, Inc.	EWTX	Unlock Forecast - 30 Days FREE Trial	$2508M	-19,7x	4,5x
Fortress Biotech, Inc.	FBIO	Unlock Forecast - 30 Days FREE Trial	$87M	-0,2x	1,6x
Fortress Biotech, Inc.	FBIOP	Unlock Forecast - 30 Days FREE Trial	$214M	-0,6x	3,8x
FibroBiologics, Inc.	FBLG	Unlock Forecast - 30 Days FREE Trial	$11M	x	86,6x
Forte Biosciences, Inc.	FBRX	Unlock Forecast - 30 Days FREE Trial	$250M	-11,5x	3,0x
FIBROGEN INC	FGEN	Unlock Forecast - 30 Days FREE Trial	$36M	-0,2x	-3,6x
Foghorn Therapeutics Inc.	FHTX	Unlock Forecast - 30 Days FREE Trial	$247M	-3,3x	-5,5x
Flora Growth Corp.	FLGC	Unlock Forecast - 30 Days FREE Trial	$6M	-4,2x	0,1x
AMICUS THERAPEUTICS, INC.	FOLD	Unlock Forecast - 30 Days FREE Trial	$3070M	-8,5x	13,3x
Fulcrum Therapeutics, Inc.	FULC	Unlock Forecast - 30 Days FREE Trial	$504M	-36,1x	2,5x
GALECTIN THERAPEUTICS INC	GALT	Unlock Forecast - 30 Days FREE Trial	$376M	-2,4x	-1,6x
Gain Therapeutics, Inc.	GANX	Unlock Forecast - 30 Days FREE Trial	$126M	-1,4x	21,3x
Generation Bio Co.	GBIO	Unlock Forecast - 30 Days FREE Trial	$36M	-0,6x	0,7x
GERON CORP	GERN	Unlock Forecast - 30 Days FREE Trial	$856M	-11,9x	3,4x
Galmed Pharmaceuticals Ltd.	GLMD	Unlock Forecast - 30 Days FREE Trial	$5M	x	0,3x
Greenwich LifeSciences, Inc.	GLSI	Unlock Forecast - 30 Days FREE Trial	$120M	-17,2x	55,1x
Galecto, Inc.	GLTO	Unlock Forecast - 30 Days FREE Trial	$24M	-2,5x	3,0x
GENELUX Corp	GNLX	Unlock Forecast - 30 Days FREE Trial	$177M	-2,8x	9,5x
Genprex, Inc.	GNPX	Unlock Forecast - 30 Days FREE Trial	$3M	-3,2x	3,8x
Gossamer Bio, Inc.	GOSS	Unlock Forecast - 30 Days FREE Trial	$755M	-3,2x	-61,8x
Structure Therapeutics Inc.	GPCR	Unlock Forecast - 30 Days FREE Trial	$5980M	-44,0x	7,8x
Grace Therapeutics, Inc.	GRCE	Unlock Forecast - 30 Days FREE Trial	$45M	-3,9x	0,7x
GRI Bio, Inc.	GRI	Unlock Forecast - 30 Days FREE Trial	$7M	-0,1x	3,3x
Galera Therapeutics, Inc.	GRTX	Unlock Forecast - 30 Days FREE Trial	$2M	-0,3x	-0,1x
GYRE THERAPEUTICS, INC.	GYRE	Unlock Forecast - 30 Days FREE Trial	$713M	60,4x	7,0x
HUTCHMED (China) Ltd	HCM	Unlock Forecast - 30 Days FREE Trial	$12356M	x	10,1x
Hepion Pharmaceuticals, Inc.	HEPA	Unlock Forecast - 30 Days FREE Trial	$1M	-0,1x	0,2x
HUTCHMED (China) Ltd	HMDCF	Unlock Forecast - 30 Days FREE Trial	$2530M	x	2,1x
HOOKIPA Pharma Inc.	HOOK	Unlock Forecast - 30 Days FREE Trial	$11M	-1,0x	0,3x
Hoth Therapeutics, Inc.	HOTH	Unlock Forecast - 30 Days FREE Trial	$18M	-0,5x	2,2x
Werewolf Therapeutics, Inc.	HOWL	Unlock Forecast - 30 Days FREE Trial	$47M	-1,3x	1,6x
Harmony Biosciences Holdings, Inc.	HRMY	Unlock Forecast - 30 Days FREE Trial	$2203M	11,9x	2,6x
HERON THERAPEUTICS, INC. /DE/	HRTX	Unlock Forecast - 30 Days FREE Trial	$185M	-6,4x	12,4x
HST Global, Inc.	HSTC	Unlock Forecast - 30 Days FREE Trial	$5M	x	x
iBio, Inc.	IBIO	Unlock Forecast - 30 Days FREE Trial	$23M	-0,4x	0,4x
IMPACT BIOMEDICAL INC.	IBO	Unlock Forecast - 30 Days FREE Trial	$6M	x	6,5x
IDEAYA Biosciences, Inc.	IDYA	Unlock Forecast - 30 Days FREE Trial	$3157M	-12,2x	2,9x
IGC Pharma, Inc.	IGC	Unlock Forecast - 30 Days FREE Trial	$29M	-4,6x	3,6x
Immunome Inc.	IMNM	Unlock Forecast - 30 Days FREE Trial	$1842M	-2,4x	7,0x
Imunon, Inc.	IMNN	Unlock Forecast - 30 Days FREE Trial	$12M	-0,5x	2,9x
Immuneering Corp	IMRX	Unlock Forecast - 30 Days FREE Trial	$244M	-0,8x	1,1x
EOM Pharmaceutical Holdings, Inc.	IMUC	Unlock Forecast - 30 Days FREE Trial	$8M	x	2,5x
IMMUNIC, INC.	IMUX	Unlock Forecast - 30 Days FREE Trial	$70M	-0,8x	6,7x
INTEGRATED BIOPHARMA INC	INBP	Unlock Forecast - 30 Days FREE Trial	$10M	x	0,5x
Indaptus Therapeutics, Inc.	INDP	Unlock Forecast - 30 Days FREE Trial	$4M	-0,6x	0,8x
INDIVIOR PLC	INDV	Unlock Forecast - 30 Days FREE Trial	$4394M	40,7x	x
InMed Pharmaceuticals Inc.	INM	Unlock Forecast - 30 Days FREE Trial	$3M	-51,8x	0,3x
INOVIO PHARMACEUTICALS, INC.	INO	Unlock Forecast - 30 Days FREE Trial	$110M	-0,6x	2,7x
INSMED Inc	INSM	Unlock Forecast - 30 Days FREE Trial	$43367M	-14,0x	45,9x
Inhibitor Therapeutics, Inc.	INTI	Unlock Forecast - 30 Days FREE Trial	$9M	x	2498,9x
Innoviva, Inc.	INVA	Unlock Forecast - 30 Days FREE Trial	$1555M	12,2x	2,8x
IO Biotech, Inc.	IOBT	Unlock Forecast - 30 Days FREE Trial	$50M	-0,7x	55,1x
IONIS PHARMACEUTICALS INC	IONS	Unlock Forecast - 30 Days FREE Trial	$13162M	-14,6x	21,3x
Opus Genetics, Inc.	IRD	Unlock Forecast - 30 Days FREE Trial	$132M	-2,0x	22,2x
Disc Medicine, Inc.	IRON	Unlock Forecast - 30 Days FREE Trial	$3283M	-18,4x	5,7x
IRONWOOD PHARMACEUTICALS INC	IRWD	Unlock Forecast - 30 Days FREE Trial	$560M	19,6x	-0,4x
International Stem Cell CORP	ISCO	Unlock Forecast - 30 Days FREE Trial	$1M	x	x
Iterum Therapeutics plc	ITRM	Unlock Forecast - 30 Days FREE Trial	$18M	-0,8x	0,0x
Incannex Healthcare Inc.	IXHL	Unlock Forecast - 30 Days FREE Trial	$125M	x	1,6x
Jaguar Health, Inc.	JAGX	Unlock Forecast - 30 Days FREE Trial	$2M	-0,2x	0,3x
Janux Therapeutics, Inc.	JANX	Unlock Forecast - 30 Days FREE Trial	$986M	-63,7x	1,0x
Jazz Pharmaceuticals plc	JAZZ	Unlock Forecast - 30 Days FREE Trial	$10344M	14,3x	2,6x
Jade Biosciences, Inc.	JBIO	Unlock Forecast - 30 Days FREE Trial	$450M	x	2,5x
JOHNSON & JOHNSON	JNJ	Unlock Forecast - 30 Days FREE Trial	$489640M	19,5x	6,2x
JUPITER NEUROSCIENCES, INC.	JUNS	Unlock Forecast - 30 Days FREE Trial	$42M	x	731,7x
KALA BIO, Inc.	KALA	Unlock Forecast - 30 Days FREE Trial	$7M	-0,5x	6,5x
KalVista Pharmaceuticals, Inc.	KALV	Unlock Forecast - 30 Days FREE Trial	$817M	-2,6x	48,1x
Kairos Pharma, LTD.	KAPA	Unlock Forecast - 30 Days FREE Trial	$16M	x	2,1x
Kaya Holdings, Inc.	KAYS	Unlock Forecast - 30 Days FREE Trial	$27M	x	x
Kiniksa Pharmaceuticals International, plc	KNSA	Unlock Forecast - 30 Days FREE Trial	$3198M	89,1x	6,0x
KIORA PHARMACEUTICALS INC	KPRX	Unlock Forecast - 30 Days FREE Trial	$7M	-2,4x	0,3x
Karyopharm Therapeutics Inc.	KPTI	Unlock Forecast - 30 Days FREE Trial	$48M	-0,6x	-0,2x
Keros Therapeutics, Inc.	KROS	Unlock Forecast - 30 Days FREE Trial	$867M	13,5x	1,2x
Korro Bio, Inc.	KRRO	Unlock Forecast - 30 Days FREE Trial	$54M	-7,9x	1,6x
Pasithea Therapeutics Corp.	KTTA	Unlock Forecast - 30 Days FREE Trial	$9M	-73,5x	0,8x
Kura Oncology, Inc.	KURA	Unlock Forecast - 30 Days FREE Trial	$1041M	-4,5x	4,3x
Kezar Life Sciences, Inc.	KZR	Unlock Forecast - 30 Days FREE Trial	$45M	-3,2x	0,6x
Lexaria Bioscience Corp.	LEXX	Unlock Forecast - 30 Days FREE Trial	$22M	-29,3x	7,2x
Longeveron Inc.	LGVN	Unlock Forecast - 30 Days FREE Trial	$10707M	-0,5x	1074,3x
LianBio	LIANY	Unlock Forecast - 30 Days FREE Trial	$9M	x	0,0x
LFTD PARTNERS INC.	LIFD	Unlock Forecast - 30 Days FREE Trial	$3M	x	0,1x
LIPELLA PHARMACEUTICALS INC.	LIPO	Unlock Forecast - 30 Days FREE Trial	$2M	-3,3x	1,0x
LIXTE BIOTECHNOLOGY HOLDINGS, INC.	LIXT	Unlock Forecast - 30 Days FREE Trial	$24M	-0,9x	5,0x
LIXTE BIOTECHNOLOGY HOLDINGS, INC.	LIXTW	Unlock Forecast - 30 Days FREE Trial	$0M	x	0,0x
ELI LILLY & Co	LLY	Unlock Forecast - 30 Days FREE Trial	$908976M	49,4x	38,2x
Lipocine Inc.	LPCN	Unlock Forecast - 30 Days FREE Trial	$18M	-2,6x	1,3x
CYPHERPUNK TECHNOLOGIES INC.	LPTX	Unlock Forecast - 30 Days FREE Trial	$94M	-1,1x	35,1x
Liquidia Corp	LQDA	Unlock Forecast - 30 Days FREE Trial	$2945M	-7,2x	133,5x
Larimar Therapeutics, Inc.	LRMR	Unlock Forecast - 30 Days FREE Trial	$316M	-0,8x	2,3x
LISATA THERAPEUTICS, INC.	LSTA	Unlock Forecast - 30 Days FREE Trial	$18M	-1,0x	1,0x
Lantern Pharma Inc.	LTRN	Unlock Forecast - 30 Days FREE Trial	$40M	-2,4x	4,2x
LAVA Therapeutics NV	LVTX	Unlock Forecast - 30 Days FREE Trial	$46M	x	3,6x
LEXICON PHARMACEUTICALS, INC.	LXRX	Unlock Forecast - 30 Days FREE Trial	$518M	-1,2x	4,3x
Lyell Immunopharma, Inc.	LYEL	Unlock Forecast - 30 Days FREE Trial	$480M	-1,1x	1,5x
MAIA Biotechnology, Inc.	MAIA	Unlock Forecast - 30 Days FREE Trial	$41M	-1,4x	975,6x
MUSTANG BIO, INC.	MBIO	Unlock Forecast - 30 Days FREE Trial	$6M	-0,1x	0,6x
Moleculin Biotech, Inc.	MBRX	Unlock Forecast - 30 Days FREE Trial	$337M	-2,3x	269,8x
MBX Biosciences, Inc.	MBX	Unlock Forecast - 30 Days FREE Trial	$1366M	x	3,5x
Seres Therapeutics, Inc.	MCRB	Unlock Forecast - 30 Days FREE Trial	$154M	-1,0x	3,5x
Medicus Pharma Ltd.	MDCX	Unlock Forecast - 30 Days FREE Trial	$46M	x	x
Medicus Pharma Ltd.	MDCXW	Unlock Forecast - 30 Days FREE Trial	$52M	x	x
MADRIGAL PHARMACEUTICALS, INC.	MDGL	Unlock Forecast - 30 Days FREE Trial	$13107M	-5,7x	21,0x
Chrome Holding Co.	MEHCQ	Unlock Forecast - 30 Days FREE Trial	$89M	x	x
MACROGENICS INC	MGNX	Unlock Forecast - 30 Days FREE Trial	$97M	-2,1x	1,5x
MIRA PHARMACEUTICALS, INC.	MIRA	Unlock Forecast - 30 Days FREE Trial	$58M	-1,6x	7,8x
Mirum Pharmaceuticals, Inc.	MIRM	Unlock Forecast - 30 Days FREE Trial	$3671M	-20,0x	12,6x
Milestone Pharmaceuticals Inc.	MIST	Unlock Forecast - 30 Days FREE Trial	$145M	-2,0x	7,1x
MoonLake Immunotherapeutics	MLTX	Unlock Forecast - 30 Days FREE Trial	$950M	-50,8x	3,3x
Mineralys Therapeutics, Inc.	MLYS	Unlock Forecast - 30 Days FREE Trial	$3073M	-4,5x	5,3x
MANNKIND CORP	MNKD	Unlock Forecast - 30 Days FREE Trial	$1753M	60,0x	-20,2x
MEDICINOVA INC	MNOV	Unlock Forecast - 30 Days FREE Trial	$71M	-7,1x	1,6x
Monopar Therapeutics	MNPR	Unlock Forecast - 30 Days FREE Trial	$546M	-3,0x	3,9x
Mereo BioPharma Group plc	MREO	Unlock Forecast - 30 Days FREE Trial	$1640M	x	35,2x
Merck & Co., Inc.	MRK	Unlock Forecast - 30 Days FREE Trial	$250696M	13,2x	4,8x
Marker Therapeutics, Inc.	MRKR	Unlock Forecast - 30 Days FREE Trial	$21M	-0,6x	1,1x
Mersana Therapeutics, Inc.	MRSN	Unlock Forecast - 30 Days FREE Trial	$137M	-3,4x	-1,4x
Merus N.V.	MRUS	Unlock Forecast - 30 Days FREE Trial	$7291M	-13,5x	9,4x
MARAVAI LIFESCIENCES HOLDINGS, INC.	MRVI	Unlock Forecast - 30 Days FREE Trial	$533M	-5,6x	2,2x
Matinas BioPharma Holdings, Inc.	MTNB	Unlock Forecast - 30 Days FREE Trial	$4M	-1,7x	0,7x
Metsera, Inc.	MTSR	Unlock Forecast - 30 Days FREE Trial	$7413M	x	22,0x
MetaVia Inc.	MTVA	Unlock Forecast - 30 Days FREE Trial	$19M	-0,5x	3,0x
Mural Oncology plc	MURA	Unlock Forecast - 30 Days FREE Trial	$35M	x	0,6x
NewAmsterdam Pharma Co N.V.	NAMS	Unlock Forecast - 30 Days FREE Trial	$4057M	x	5,6x
NewAmsterdam Pharma Co N.V.	NAMSW	Unlock Forecast - 30 Days FREE Trial	$3361M	x	4,6x
NATURES SUNSHINE PRODUCTS INC	NATR	Unlock Forecast - 30 Days FREE Trial	$386M	25,6x	2,4x
NovaBay Pharmaceuticals, Inc.	NBY	Unlock Forecast - 30 Days FREE Trial	$7M	-1,8x	5,9x
Minerva Neurosciences, Inc.	NERV	Unlock Forecast - 30 Days FREE Trial	$29M	-0,8x	-0,5x
Neuphoria Therapeutics Inc.	NEUP	Unlock Forecast - 30 Days FREE Trial	$10M	x	0,8x
Neurogene Inc.	NGNE	Unlock Forecast - 30 Days FREE Trial	$306M	-7,3x	1,2x
NIKA PHARMACEUTICALS, INC	NIKA	Unlock Forecast - 30 Days FREE Trial	$260M	x	x
NEKTAR THERAPEUTICS	NKTR	Unlock Forecast - 30 Days FREE Trial	$11170M	-1,2x	131,3x
Nkarta, Inc.	NKTX	Unlock Forecast - 30 Days FREE Trial	$135M	-1,3x	0,4x
NewcelX Ltd.	NLSP	Unlock Forecast - 30 Days FREE Trial	$54M	x	98,9x
NewcelX Ltd.	NLSPW	Unlock Forecast - 30 Days FREE Trial	$0M	x	0,2x
NANOVIRICIDES, INC.	NNVC	Unlock Forecast - 30 Days FREE Trial	$21M	-2,1x	3,0x
Nurix Therapeutics, Inc.	NRIX	Unlock Forecast - 30 Days FREE Trial	$1385M	-7,4x	3,7x
NeuroSense Therapeutics Ltd.	NRSN	Unlock Forecast - 30 Days FREE Trial	$29M	x	x
NRX Pharmaceuticals, Inc.	NRXP	Unlock Forecast - 30 Days FREE Trial	$67M	-0,6x	-2,1x
NEONC TECHNOLOGIES HOLDINGS, INC.	NTHI	Unlock Forecast - 30 Days FREE Trial	$179M	x	x
Nuvation Bio Inc.	NUVB	Unlock Forecast - 30 Days FREE Trial	$2807M	-1,2x	8,6x
Nuvalent, Inc.	NUVL	Unlock Forecast - 30 Days FREE Trial	$7877M	-30,9x	9,3x
Nuvectis Pharma, Inc.	NVCT	Unlock Forecast - 30 Days FREE Trial	$172M	-3,9x	7,2x
NORTHWEST BIOTHERAPEUTICS INC	NWBO	Unlock Forecast - 30 Days FREE Trial	$361M	x	x
NEXIEN BIOPHARMA, INC.	NXEN	Unlock Forecast - 30 Days FREE Trial	$0M	x	x
NextCure, Inc.	NXTC	Unlock Forecast - 30 Days FREE Trial	$38M	-0,5x	1,6x
Ocean Biomedical, Inc.	OCEA	Unlock Forecast - 30 Days FREE Trial	$1M	-0,3x	0,0x
OCULAR THERAPEUTIX, INC	OCUL	Unlock Forecast - 30 Days FREE Trial	$2175M	-8,2x	8,4x
ORAGENICS INC	OGEN	Unlock Forecast - 30 Days FREE Trial	$4M	-0,1x	0,4x
Organon & Co.	OGN	Unlock Forecast - 30 Days FREE Trial	$1856M	3,7x	2,1x
OnKure Therapeutics, Inc.	OKUR	Unlock Forecast - 30 Days FREE Trial	$39M	-6,9x	0,6x
Olema Pharmaceuticals, Inc.	OLMA	Unlock Forecast - 30 Days FREE Trial	$1898M	-4,0x	6,2x
OMEROS CORP	OMER	Unlock Forecast - 30 Days FREE Trial	$761M	-4,2x	-0,9x
BeOne Medicines Ltd.	ONC	Unlock Forecast - 30 Days FREE Trial	$464357M	6774,0x	112,5x
Onconetix, Inc.	ONCO	Unlock Forecast - 30 Days FREE Trial	$4M	-0,3x	0,1x
OPKO HEALTH, INC.	OPK	Unlock Forecast - 30 Days FREE Trial	$1004M	-3,5x	0,8x
Organogenesis Holdings Inc.	ORGO	Unlock Forecast - 30 Days FREE Trial	$615M	611,8x	2,4x
Orgenesis Inc.	ORGS	Unlock Forecast - 30 Days FREE Trial	$1M	0,9x	-3,7x
Oric Pharmaceuticals, Inc.	ORIC	Unlock Forecast - 30 Days FREE Trial	$1134M	-4,2x	2,8x
Oruka Therapeutics, Inc.	ORKA	Unlock Forecast - 30 Days FREE Trial	$1497M	x	3,1x
ORAMED PHARMACEUTICALS INC.	ORMP	Unlock Forecast - 30 Days FREE Trial	$114M	21,9x	0,6x
OS Therapies Inc	OSTX	Unlock Forecast - 30 Days FREE Trial	$60M	x	16,4x
Oncotelic Therapeutics, Inc.	OTLC	Unlock Forecast - 30 Days FREE Trial	$44M	x	4,9x
Ovid Therapeutics Inc.	OVID	Unlock Forecast - 30 Days FREE Trial	$127M	-2,6x	2,8x
One World Products, Inc.	OWPC	Unlock Forecast - 30 Days FREE Trial	$2M	x	x
PHIBRO ANIMAL HEALTH CORP	PAHC	Unlock Forecast - 30 Days FREE Trial	$1667M	24,6x	5,4x
Prestige Consumer Healthcare Inc.	PBH	Unlock Forecast - 30 Days FREE Trial	$2976M	14,8x	1,6x
PUMA BIOTECHNOLOGY, INC.	PBYI	Unlock Forecast - 30 Days FREE Trial	$267M	7,2x	2,3x
Pacira BioSciences, Inc.	PCRX	Unlock Forecast - 30 Days FREE Trial	$1042M	48,6x	1,4x
Processa Pharmaceuticals, Inc.	PCSA	Unlock Forecast - 30 Days FREE Trial	$14M	-0,5x	2,4x
PDS Biotechnology Corp	PDSB	Unlock Forecast - 30 Days FREE Trial	$37M	-1,7x	3,9x
PepGen Inc.	PEPG	Unlock Forecast - 30 Days FREE Trial	$177M	-1,6x	1,1x
PFIZER INC	PFE	Unlock Forecast - 30 Days FREE Trial	$148631M	15,1x	1,6x
PRECIGEN, INC.	PGEN	Unlock Forecast - 30 Days FREE Trial	$1327M	-1,4x	31,7x
Phathom Pharmaceuticals, Inc.	PHAT	Unlock Forecast - 30 Days FREE Trial	$1044M	-1,6x	-1,6x
Phio Pharmaceuticals Corp.	PHIO	Unlock Forecast - 30 Days FREE Trial	$7M	-0,8x	0,7x
ProtoKinetix, Inc.	PKTX	Unlock Forecast - 30 Days FREE Trial	$3M	x	10,6x
Plandai Biotechnology, Inc.	PLPL	Unlock Forecast - 30 Days FREE Trial	$0M	x	x
PLIANT THERAPEUTICS, INC.	PLRX	Unlock Forecast - 30 Days FREE Trial	$99M	-4,5x	0,5x
Polomar Health Services, Inc.	PMHS	Unlock Forecast - 30 Days FREE Trial	$2M	x	0,3x
ProMIS Neurosciences Inc.	PMN	Unlock Forecast - 30 Days FREE Trial	$364M	-2,1x	39,6x
PMV Pharmaceuticals, Inc.	PMVP	Unlock Forecast - 30 Days FREE Trial	$70M	-1,6x	0,6x
Propanc Biopharma, Inc.	PPCB	Unlock Forecast - 30 Days FREE Trial	$11M	x	0,8x
Praxis Precision Medicines, Inc.	PRAX	Unlock Forecast - 30 Days FREE Trial	$5249M	-4,0x	15,3x
PAINREFORM LTD.	PRFX	Unlock Forecast - 30 Days FREE Trial	$3M	x	x
PERRIGO Co plc	PRGO	Unlock Forecast - 30 Days FREE Trial	$1856M	-27,6x	0,4x
Prelude Therapeutics Inc	PRLD	Unlock Forecast - 30 Days FREE Trial	$128M	-0,5x	2,2x
ProPhase Labs, Inc.	PRPH	Unlock Forecast - 30 Days FREE Trial	$9M	-0,5x	1,3x
PROTHENA CORP PUBLIC LTD CO	PRTA	Unlock Forecast - 30 Days FREE Trial	$598M	-12,4x	2,0x
PTC THERAPEUTICS, INC.	PTCT	Unlock Forecast - 30 Days FREE Trial	$6175M	8,2x	-20,3x
Protagonist Therapeutics, Inc	PTGX	Unlock Forecast - 30 Days FREE Trial	$5598M	121,9x	8,7x
Protagenic Therapeutics, Inc.\new	PTIX	Unlock Forecast - 30 Days FREE Trial	$4M	-2,8x	-22,8x
PALATIN TECHNOLOGIES INC	PTNT	Unlock Forecast - 30 Days FREE Trial	$19M	x	48,0x
Petros Pharmaceuticals, Inc.	PTPI	Unlock Forecast - 30 Days FREE Trial	$0M	-0,1x	0,2x
Pulmatrix, Inc.	PULM	Unlock Forecast - 30 Days FREE Trial	$16M	-1,8x	3,4x
PROVECTUS BIOPHARMACEUTICALS, INC.	PVCT	Unlock Forecast - 30 Days FREE Trial	$26M	x	x
PALVELLA THERAPEUTICS, INC.	PVLA	Unlock Forecast - 30 Days FREE Trial	$1040M	x	26,9x
Pyxis Oncology, Inc.	PYXS	Unlock Forecast - 30 Days FREE Trial	$264M	-1,3x	3,8x
AIxCrypto Holdings, Inc.	QLGN	Unlock Forecast - 30 Days FREE Trial	$8M	-1,3x	0,2x
Quoin Pharmaceuticals, Ltd.	QNRX	Unlock Forecast - 30 Days FREE Trial	$448M	x	120,1x
Q32 Bio Inc.	QTTB	Unlock Forecast - 30 Days FREE Trial	$27M	-0,7x	-6,7x
uniQure N.V.	QURE	Unlock Forecast - 30 Days FREE Trial	$1414M	-2,8x	6,2x
Rani Therapeutics Holdings, Inc.	RANI	Unlock Forecast - 30 Days FREE Trial	$62M	-1,3x	0,0x
Rapport Therapeutics, Inc.	RAPP	Unlock Forecast - 30 Days FREE Trial	$1368M	x	2,7x
RAPT Therapeutics, Inc.	RAPT	Unlock Forecast - 30 Days FREE Trial	$917M	-0,4x	6,0x
Ultragenyx Pharmaceutical Inc.	RARE	Unlock Forecast - 30 Days FREE Trial	$3524M	-7,0x	384,8x
ROCKET PHARMACEUTICALS, INC.	RCKT	Unlock Forecast - 30 Days FREE Trial	$359M	-4,8x	1,2x
Arcus Biosciences, Inc.	RCUS	Unlock Forecast - 30 Days FREE Trial	$2705M	-5,5x	6,2x
REGENERON PHARMACEUTICALS, INC.	REGN	Unlock Forecast - 30 Days FREE Trial	$78229M	17,1x	2,5x
REVELATION BIOSCIENCES, INC.	REVB	Unlock Forecast - 30 Days FREE Trial	$3M	-0,1x	0,3x
Rafael Holdings, Inc.	RFL	Unlock Forecast - 30 Days FREE Trial	$35M	-0,9x	0,4x
Regen BioPharma Inc	RGBP	Unlock Forecast - 30 Days FREE Trial	$0M	x	x
Regen BioPharma Inc	RGBPP	Unlock Forecast - 30 Days FREE Trial	$3M	x	x
RIGEL PHARMACEUTICALS INC	RIGL	Unlock Forecast - 30 Days FREE Trial	$873M	7,7x	7,4x
RELMADA THERAPEUTICS, INC.	RLMD	Unlock Forecast - 30 Days FREE Trial	$139M	-0,1x	14,7x
Rallybio Corp	RLYB	Unlock Forecast - 30 Days FREE Trial	$27M	-0,7x	0,4x
ROCKWELL MEDICAL, INC.	RMTI	Unlock Forecast - 30 Days FREE Trial	$39M	-17,1x	1,1x
Avidity Biosciences, Inc.	RNA	Unlock Forecast - 30 Days FREE Trial	$10513M	-12,2x	5,6x
Cartesian Therapeutics, Inc.	RNAC	Unlock Forecast - 30 Days FREE Trial	$179M	-2,1x	-14,1x
Transcode Therapeutics, Inc.	RNAZ	Unlock Forecast - 30 Days FREE Trial	$8M	-0,2x	5,4x
Rein Therapeutics, Inc.	RNTX	Unlock Forecast - 30 Days FREE Trial	$39M	x	0,9x
RenovoRx, Inc.	RNXT	Unlock Forecast - 30 Days FREE Trial	$32M	-3,4x	4,0x
Roivant Sciences Ltd.	ROIV	Unlock Forecast - 30 Days FREE Trial	$14463M	1,8x	3,3x
Royalty Pharma plc	RPRX	Unlock Forecast - 30 Days FREE Trial	$22517M	29,4x	3,5x
Repare Therapeutics Inc.	RPTX	Unlock Forecast - 30 Days FREE Trial	$91M	-2,1x	0,8x
Rapid Therapeutic Science Laboratories, Inc.	RTSL	Unlock Forecast - 30 Days FREE Trial	$0M	0,5x	x
REVIVA PHARMACEUTICALS HOLDINGS, INC.	RVPH	Unlock Forecast - 30 Days FREE Trial	$54M	-4,1x	11,9x
RHYTHM PHARMACEUTICALS, INC.	RYTM	Unlock Forecast - 30 Days FREE Trial	$6975M	-20,3x	46,9x
Rezolute, Inc.	RZLT	Unlock Forecast - 30 Days FREE Trial	$927M	-3,9x	6,3x
CASSAVA SCIENCES INC	SAVA	Unlock Forecast - 30 Days FREE Trial	$157M	-1,9x	1,9x
Sunshine Biopharma Inc.	SBFM	Unlock Forecast - 30 Days FREE Trial	$6M	-0,6x	0,3x
Scienture Holdings, Inc.	SCNX	Unlock Forecast - 30 Days FREE Trial	$14M	2,9x	0,2x
scPharmaceuticals Inc.	SCPH	Unlock Forecast - 30 Days FREE Trial	$302M	-2,0x	-50,9x
SCYNEXIS INC	SCYX	Unlock Forecast - 30 Days FREE Trial	$29M	-2,4x	0,8x
Schrodinger, Inc.	SDGR	Unlock Forecast - 30 Days FREE Trial	$1351M	-7,8x	4,2x
Septerna, Inc.	SEPN	Unlock Forecast - 30 Days FREE Trial	$1168M	x	3,0x
Serina Therapeutics, Inc.	SER	Unlock Forecast - 30 Days FREE Trial	$45M	22,6x	25,5x
Sagimet Biosciences Inc.	SGMT	Unlock Forecast - 30 Days FREE Trial	$205M	x	1,7x
Sionna Therapeutics, Inc.	SION	Unlock Forecast - 30 Days FREE Trial	$1818M	x	5,7x
SKINVISIBLE, INC.	SKVI	Unlock Forecast - 30 Days FREE Trial	$2M	x	x
Skye Bioscience, Inc.	SKYE	Unlock Forecast - 30 Days FREE Trial	$39M	-0,7x	1,2x
Sol-Gel Technologies Ltd.	SLGL	Unlock Forecast - 30 Days FREE Trial	$118M	x	3,7x
Silence Therapeutics plc	SLN	Unlock Forecast - 30 Days FREE Trial	$986M	x	13,3x
Silence Therapeutics plc	SLNCF	Unlock Forecast - 30 Days FREE Trial	$255M	x	3,4x
SOLENO THERAPEUTICS INC	SLNO	Unlock Forecast - 30 Days FREE Trial	$2829M	-18,5x	5,7x
Salarius Pharmaceuticals, Inc.	SLRX	Unlock Forecast - 30 Days FREE Trial	$1M	-0,5x	0,2x
SELLAS Life Sciences Group, Inc.	SLS	Unlock Forecast - 30 Days FREE Trial	$218M	-1,0x	4,8x
Summit Therapeutics Inc.	SMMT	Unlock Forecast - 30 Days FREE Trial	$13631M	104,1x	70,9x
Syndax Pharmaceuticals Inc	SNDX	Unlock Forecast - 30 Days FREE Trial	$1716M	-4,1x	14,9x
SOLIGENIX, INC.	SNGX	Unlock Forecast - 30 Days FREE Trial	$16M	-1,8x	2,1x
Sibannac, Inc.	SNNC	Unlock Forecast - 30 Days FREE Trial	$0M	x	x
Sensei Biotherapeutics, Inc.	SNSE	Unlock Forecast - 30 Days FREE Trial	$11M	-0,4x	0,5x
Sonnet BioTherapeutics Holdings, Inc.	SONN	Unlock Forecast - 30 Days FREE Trial	$12M	-1,6x	29,5x
SPRUCE BIOSCIENCES, INC.	SPRB	Unlock Forecast - 30 Days FREE Trial	$56M	-0,4x	10,5x
Spero Therapeutics, Inc.	SPRO	Unlock Forecast - 30 Days FREE Trial	$135M	-17,8x	5,1x
ARS Pharmaceuticals, Inc.	SPRY	Unlock Forecast - 30 Days FREE Trial	$980M	-23,5x	6,6x
Sarepta Therapeutics, Inc.	SRPT	Unlock Forecast - 30 Days FREE Trial	$2391M	162,5x	1,8x
Stoke Therapeutics, Inc.	STOK	Unlock Forecast - 30 Days FREE Trial	$1711M	42,2x	5,6x
SUPERNUS PHARMACEUTICALS, INC.	SUPN	Unlock Forecast - 30 Days FREE Trial	$2576M	46,0x	2,5x
Savara Inc	SVRA	Unlock Forecast - 30 Days FREE Trial	$1123M	-8,2x	11,9x
60 DEGREES PHARMACEUTICALS, INC.	SXTP	Unlock Forecast - 30 Days FREE Trial	$4M	-0,6x	1,0x
SYNLOGIC, INC.	SYBX	Unlock Forecast - 30 Days FREE Trial	$17M	3,6x	1,6x
Spyre Therapeutics, Inc.	SYRE	Unlock Forecast - 30 Days FREE Trial	$2026M	-0,7x	4,5x
Theravance Biopharma, Inc.	TBPH	Unlock Forecast - 30 Days FREE Trial	$940M	32,0x	4,0x
Alaunos Therapeutics, Inc.	TCRT	Unlock Forecast - 30 Days FREE Trial	$7M	-1,0x	2,6x
Telomir Pharmaceuticals, Inc.	TELO	Unlock Forecast - 30 Days FREE Trial	$45M	x	6,5x
TENAX THERAPEUTICS, INC.	TENX	Unlock Forecast - 30 Days FREE Trial	$54M	-14,9x	0,6x
Terns Pharmaceuticals, Inc.	TERN	Unlock Forecast - 30 Days FREE Trial	$2374M	-5,1x	8,4x
TEVA PHARMACEUTICAL INDUSTRIES LTD	TEVA	Unlock Forecast - 30 Days FREE Trial	$33014M	46,3x	4,6x
TEVA PHARMACEUTICAL INDUSTRIES LTD	TEVJF	Unlock Forecast - 30 Days FREE Trial	$30160M	x	4,2x
TG THERAPEUTICS, INC.	TGTX	Unlock Forecast - 30 Days FREE Trial	$4774M	10,7x	7,9x
TALPHERA, INC.	TLPH	Unlock Forecast - 30 Days FREE Trial	$61M	-2,3x	3,2x
Tango Therapeutics, Inc.	TNGX	Unlock Forecast - 30 Days FREE Trial	$1105M	-2,8x	6,9x
Tonix Pharmaceuticals Holding Corp.	TNXP	Unlock Forecast - 30 Days FREE Trial	$200M	0,0x	0,9x
Theriva Biologics, Inc.	TOVX	Unlock Forecast - 30 Days FREE Trial	$3M	-0,4x	0,0x
Tempest Therapeutics, Inc.	TPST	Unlock Forecast - 30 Days FREE Trial	$14M	-0,5x	2,2x
Traws Pharma, Inc.	TRAW	Unlock Forecast - 30 Days FREE Trial	$19M	-0,6x	1,7x
Entrada Therapeutics, Inc.	TRDA	Unlock Forecast - 30 Days FREE Trial	$396M	6,9x	1,2x
Trevi Therapeutics, Inc.	TRVI	Unlock Forecast - 30 Days FREE Trial	$1727M	-6,1x	9,1x
Tvardi Therapeutics, Inc.	TVRD	Unlock Forecast - 30 Days FREE Trial	$39M	x	1,4x
TherapeuticsMD, Inc.	TXMD	Unlock Forecast - 30 Days FREE Trial	$20M	-2,2x	0,7x
Tyra Biosciences, Inc.	TYRA	Unlock Forecast - 30 Days FREE Trial	$1187M	-9,5x	4,2x
Unicycive Therapeutics, Inc.	UNCY	Unlock Forecast - 30 Days FREE Trial	$135M	-0,9x	3,6x
Upstream Bio, Inc.	UPB	Unlock Forecast - 30 Days FREE Trial	$1498M	x	4,0x
UroGen Pharma Ltd.	URGN	Unlock Forecast - 30 Days FREE Trial	$1136M	-2,5x	-15,2x
UNITED THERAPEUTICS Corp	UTHR	Unlock Forecast - 30 Days FREE Trial	$20993M	16,5x	3,2x
VACCINEX, INC.	VCNX	Unlock Forecast - 30 Days FREE Trial	$2M	-0,1x	0,3x
Vera Therapeutics, Inc.	VERA	Unlock Forecast - 30 Days FREE Trial	$2717M	-20,4x	6,8x
VERU INC.	VERU	Unlock Forecast - 30 Days FREE Trial	$36M	-0,8x	2,4x
Vincerx Pharma, Inc.	VINC	Unlock Forecast - 30 Days FREE Trial	$0M	-0,2x	0,0x
Viracta Therapeutics, Inc.	VIRX	Unlock Forecast - 30 Days FREE Trial	$0M	-0,2x	-0,1x
Viking Therapeutics, Inc.	VKTX	Unlock Forecast - 30 Days FREE Trial	$4337M	-67,5x	6,1x
Vanda Pharmaceuticals Inc.	VNDA	Unlock Forecast - 30 Days FREE Trial	$322M	-16,1x	0,7x
Verrica Pharmaceuticals Inc.	VRCA	Unlock Forecast - 30 Days FREE Trial	$86M	-0,5x	-4,1x
Viridian Therapeutics, Inc.\DE	VRDN	Unlock Forecast - 30 Days FREE Trial	$2669M	-4,5x	5,3x
Vireo Growth Inc.	VREOF	Unlock Forecast - 30 Days FREE Trial	$314M	x	1,3x
Verona Pharma plc	VRNA	Unlock Forecast - 30 Days FREE Trial	$73547M	-185,1x	264,3x
VERTEX PHARMACEUTICALS INC / MA	VRTX	Unlock Forecast - 30 Days FREE Trial	$115670M	31,5x	6,7x
Verastem, Inc.	VSTM	Unlock Forecast - 30 Days FREE Trial	$696M	-6,5x	13,5x
Vistagen Therapeutics, Inc.	VTGN	Unlock Forecast - 30 Days FREE Trial	$166M	-0,1x	2,5x
Viatris Inc	VTRS	Unlock Forecast - 30 Days FREE Trial	$12861M	-29,5x	0,0x
vTv Therapeutics Inc.	VTVT	Unlock Forecast - 30 Days FREE Trial	$0M	-3,3x	-7,5x
Ventyx Biosciences, Inc.	VTYX	Unlock Forecast - 30 Days FREE Trial	$613M	-1,0x	3,2x
VYNE Therapeutics Inc.	VYNE	Unlock Forecast - 30 Days FREE Trial	$8M	-0,4x	0,2x
Whitehawk Therapeutics, Inc.	WHWK	Unlock Forecast - 30 Days FREE Trial	$110M	x	0,7x
Wave Life Sciences Ltd.	WVE	Unlock Forecast - 30 Days FREE Trial	$1221M	-22,2x	9,8x
XBiotech Inc.	XBIT	Unlock Forecast - 30 Days FREE Trial	$70M	-3,5x	0,4x
EXICURE, INC.	XCUR	Unlock Forecast - 30 Days FREE Trial	$27M	-1,9x	3,9x
Xenon Pharmaceuticals Inc.	XENE	Unlock Forecast - 30 Days FREE Trial	$3440M	-15,4x	6,2x
Xeris Biopharma Holdings, Inc.	XERS	Unlock Forecast - 30 Days FREE Trial	$1106M	54,7x	-23,8x
Xilio Therapeutics, Inc.	XLO	Unlock Forecast - 30 Days FREE Trial	$39M	-0,5x	5,9x
Xencor Inc	XNCR	Unlock Forecast - 30 Days FREE Trial	$1294M	-8,4x	2,1x
XOMA Royalty Corp	XOMA	Unlock Forecast - 30 Days FREE Trial	$379M	-11,7x	4,3x
XOMA Royalty Corp	XOMAO	Unlock Forecast - 30 Days FREE Trial	$314M	-10,1x	3,6x
XOMA Royalty Corp	XOMAP	Unlock Forecast - 30 Days FREE Trial	$328M	-10,5x	3,7x
Zenas BioPharma, Inc.	ZBIO	Unlock Forecast - 30 Days FREE Trial	$1609M	x	8,2x
Zai Lab Ltd	ZLAB	Unlock Forecast - 30 Days FREE Trial	$22062M	-95,2x	29,0x
Zentalis Pharmaceuticals, Inc.	ZNTL	Unlock Forecast - 30 Days FREE Trial	$103M	-1,4x	0,4x
Zomedica Corp.	ZOMDF	Unlock Forecast - 30 Days FREE Trial	$115M	x	1,0x
Zoetis Inc.	ZTS	Unlock Forecast - 30 Days FREE Trial	$52380M	19,8x	9,7x
ZEVRA THERAPEUTICS, INC.	ZVRA	Unlock Forecast - 30 Days FREE Trial	$489M	13,8x	3,7x
Zymeworks Inc.	ZYME	Unlock Forecast - 30 Days FREE Trial	$1993M	-8,3x	6,2x

Questions fréquemment posées - ABEONA THERAPEUTICS INC. Prévisions boursières

Quelle est la précision des prévisions boursières de ABEONA THERAPEUTICS INC. ?

Notre modèle IA démontre une précision historique de 25% pour les prédictions de ABEO, basée sur des algorithmes avancés d'apprentissage automatique entraînés sur plus de 10 ans de données de marché.

Quels facteurs influencent les prévisions du cours de l'action ABEONA THERAPEUTICS INC. ?

Notre analyse prend en compte les indicateurs financiers de ABEONA THERAPEUTICS INC., les tendances sectorielles de Life Sciences, le sentiment du marché, les indicateurs techniques, les données sur les bénéfices et les facteurs macroéconomiques qui influent sur la performance des actions.

Est-ce que ABEONA THERAPEUTICS INC. est un bon investissement en 2025 ?

D'après notre analyse de l'IA, ABEONA THERAPEUTICS INC. montre un potentiel pour différents scénarios de marché. Tenez compte de votre tolérance au risque, de votre calendrier d'investissement et de la diversification de votre portefeuille avant de prendre des décisions d'investissement.

A quelle fréquence les prévisions ABEONA THERAPEUTICS INC. sont-elles mises à jour ?

Les prévisions boursières de ABEONA THERAPEUTICS INC. sont mises à jour quotidiennement à l'aide de données de marché en temps réel, ce qui vous permet de recevoir les prévisions et les informations d'investissement les plus récentes grâce à l'IA.

Vous voulez une analyse ABEONA THERAPEUTICS INC. plus avancée ?

Déverrouillez les fonctionnalités premium, y compris les objectifs de prix détaillés, les évaluations de risque, l'optimisation du portefeuille et les alertes en temps réel pour l'action ABEONA THERAPEUTICS INC..

🎯 Obtenir une analyse Premium 📊 Explorer d'autres actions

Mon portefeuille

Tableau de bord des investissements

Chargement de votre portefeuille...

Préférences de cookies

Paramètres des cookies

Cookies essentiels

Cookies analytiques

Bienvenue !

ABEONA THERAPEUTICS INC. (ABEO) Prévision du cours de l'action par IA et analyse d'investissement ⛶Plein écran

ABEONA THERAPEUTICS INC. Graphique du cours de l'action et analyse technique